As of June 2026, 2 paid clinical trials are recruiting for Ovarian cancer in New Lenox, Illinois. Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New Lenox has approximately 63 recruiting research studies across a wide range of therapeutic areas. Illinois's research base includes Northwestern Medicine, Rush University Medical Center, University of Chicago Medicine, and Ann & Robert H. Lurie Children's Hospital, covering oncology, cardiology, and pediatric specialties.
Researchers run research studies in New Lenox, IL at 10 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UC Comprehensive Cancer Center at Silver Cross | Acute Myeloid Leukemia, Stage IV Renal Cell Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 50 |
| Hope and Healing Cancer Services | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 3 |
| University of Chicago Comprehensive Cancer Center at Silver Cross Hospital | Breast Cancer, Carcinoma, Non-Small Cell Lung, Circulating Tumor DNA | 3 |
| Advanced Urology Associates | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 1 |
| Hope and Healing Clinical Research | Carcinoma, Small Cell Lung, Lung Neoplasms, Small Cell Cancer Of The Lung | 1 |
| Hope and Healing Clinical Research LLC New Lenox- Research Department | Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma | 1 |
| Silver Cross Surgery Center | Lumbar Spinal Stenosis | 1 |
| UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital | ER Positive Breast Cancer, Estrogen Receptor Positive Tumor, HER-2 Protein Overexpression | 1 |
| University of Chicago | Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer | 1 |
| University of Chicago Comprehensive Cancer Center at Silver Cross | HER2-positive Metastatic Breast Cancer | 1 |
Recruiting trials in New Lenox grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Illinois are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Illinois studies must also comply with the Illinois Personal Information Protection Act (PIPA) and Biometric Information Privacy Act (BIPA) where applicable.
Hipa.ai aggregates every recruiting study in New Lenox from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 63 recruiting clinical trials in New Lenox, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in New Lenox compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in New Lenox include Acute Myeloid Leukemia (4), Stage IV Renal Cell Cancer AJCC v8 (4), Anatomic Stage I Breast Cancer AJCC v8 (3), Anatomic Stage II Breast Cancer AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New Lenox on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in New Lenox include UC Comprehensive Cancer Center at Silver Cross, Hope and Healing Cancer Services, University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in New Lenox are Cancer & tumors (58). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.